Preprint / Version 1

Snapshot of COVID-19 Related Clinical Trials in India

Authors

  • Jaykaran Charan Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, India
  • Rimplejeet Kaur Department of Pharmacology, S.N. Medical College, Jodhpur, India
  • Pankaj Bhardwaj Department of Community and Family Medicine, All India Institute of Medical Sciences, Jodhpur, India
  • Tanuj Kanchan Department of Forensic Medicine, All India Institute of Medical Sciences, Jodhpur, India
  • Prasenjit Mitra Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India
  • Dharmveer Yadav Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India
  • Praveen Sharma Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India
  • Sanjeev Misra Department of Surgical Oncology, All India Institute of Medical Sciences, Jodhpur, India

Keywords:

COVID 19, Trials, AYUSH, Treatment, Prophylaxis

Abstract

Many interventions are being explored for the prophylaxis and treatment of COVID-19 in all over the world including India. There was a need of systematic data about the COVID-19 related clinical trials conducted in India. The aim of the present study was to analyze various clinical trials registered in Clinical Trial Registry of India (CTRI) exploring the interventions for COVID 19. The data of various clinical trials being conducted in India was obtained from CTRI. Different trial characteristics were extracted in the predesigned proforma and analyzed. Values were expressed in frequency and percentages. As of 11th July, 2020, a total of 203 trials were registered in the CTRI. The majority of the trials (61%) were related to the AYUSH interventions. Only 3 trials were international while the others were national. A major portion of public and private funding were dedicated to the AYUSH trials. More number of trials were for treatment as compared to prophylaxis. Maharashtra and Delhi are having highest number of trial sites. There is a good progress regarding AYUSH clinical trials, and a similar progress is expected for allopathic interventions. Keywords: COVID 19, Trials, AYUSH, Treatment, Prophylaxis

Downloads